15
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Treatment of Tuberculous Meningitis in Adults with a Combination of Isoniazid, Rifampicin and Streptomycin: A Prospective Study

, &
Pages 81-85 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Mehmet Doĝanay, Semra Çalangu, Hüseyin Turgut, Mehmet Bakir & Bilgehan Aygen. (1995) Treatment of Tuberculous Meningitis in Turkey. Scandinavian Journal of Infectious Diseases 27:2, pages 135-138.
Read now

Articles from other publishers (6)

Ahmed Aliyu Abulfathi, Eric H. Decloedt, Elin M. Svensson, Andreas H. Diacon, Peter Donald & Helmuth Reuter. (2019) Clinical Pharmacokinetics and Pharmacodynamics of Rifampicin in Human Tuberculosis. Clinical Pharmacokinetics 58:9, pages 1103-1129.
Crossref
Vinay Goyal, Arunmozhimaran Elavarasi, Abhishek, Garima Shukla & Madhuri Behari. (2019) Practice trends in treating central nervous system tuberculosis and outcomes at a tertiary care hospital: A cohort study of 244 cases. Annals of Indian Academy of Neurology 22:1, pages 37.
Crossref
James A Seddon, Lillian Tugume, Regan Solomons, Kameshwar Prasad & Nathan C Bahr. (2019) The current global situation for tuberculous meningitis: epidemiology, diagnostics, treatment and outcomes. Wellcome Open Research 4, pages 167.
Crossref
Sophie Jullien, Hannah Ryan, Manish Modi & Rohit Bhatia. (2016) Six months therapy for tuberculous meningitis. Cochrane Database of Systematic Reviews 2017:9.
Crossref
P.R. Donald. (2010) The chemotherapy of tuberculous meningitis in children and adults. Tuberculosis 90:6, pages 375-392.
Crossref
M. Maurin & D. Raoult. (2001) Use of Aminoglycosides in Treatment of Infections Due to Intracellular Bacteria. Antimicrobial Agents and Chemotherapy 45:11, pages 2977-2986.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.